Inventor · disambiguated record
Subbarao Nallagatla
Also filed as: NALLAGATLA SUBBARAO
8 granted patents·9 pending applications·29 citations·filing 2014–2025
83Inventor score
Files withEXICURE INC8AVIDITY BIOSCIENCES INC3EXICURE OPERATING COMPANY3FLASHPOINT THERAPEUTICS INC2NALLAGATLA SUBBARAO1
Top patents by PatentIndex Score
17 records- 0191US11123294B2Multivalent delivery of immune modulators by liposomal spherical nucleic acids for prophylactic or therapeutic applicationsEXICURE OPERATING COMPANY·Filed 2019·Granted Sep 21, 2021·5 cites·33 claims
- 0291US10837018B2Spherical nucleic acid-based constructs as immunostimulatory agents for prophylactic and therapeutic useEXICURE INC·Filed 2018·Granted Nov 17, 2020·6 cites·20 claims
- 0389US10434064B2Multivalent delivery of immune modulators by liposomal spherical nucleic acids for prophylactic or therapeutic applicationsEXICURE INC·Filed 2015·Granted Oct 8, 2019·9 cites·10 claims
- 0488US11957788B2Multivalent delivery of immune modulators by liposomal spherical nucleic acids for prophylactic or therapeutic applicationsEXICURE OPERATING COMPANY·Filed 2021·Granted Apr 16, 2024·1 cites·20 claims
- 0587US10894963B2Spherical nucleic acid-based constructs as immunostimulatory agents for prophylactic and therapeutic useEXICURE INC·Filed 2014·Granted Jan 19, 2021·7 cites·16 claims
- 0683US12491257B2Compositions and methods of using PRKAG2-targeting antibody-oligonucleotide conjugatesAVIDITY BIOSCIENCES INC·Filed 2024·Granted Dec 9, 2025·1 cites·22 claims
- 0779US2025283096A1Spherical nucleic acid-based constructs as immunostimulatory agents for prophylactic and therapeutic useFLASHPOINT THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 0874US12409230B2Compositions comprising PLN-targeting anti-transferrin receptor antibody-polynucleotides and methods of use thereof to treat cardiomyopathyAVIDITY BIOSCIENCES INC·Filed 2024·Granted Sep 9, 2025·0 cites·27 claims
- 0966US2025352651A1Compositions comprising pln-targeting anti-transferrin receptor antibody-polynucleotides and methods of use thereof to treat cardiomyopathyAVIDITY BIOSCIENCES INC·Filed 2025·Application pending·0 cites
- 1065US2021102211A1Spherical nucleic acid-based constructs as immunostimulatory agents for prophylactic and therapeutic useEXICURE INC·Filed 2020·Application pending·0 cites
- 1162US2022064649A1Spherical nucleic acid tlr9 agonistsEXICURE INC·Filed 2021·Application pending·0 cites
- 1254US2025304974A1Tlr9-targeted spherical nucleic acids having potent antitumor activityFLASHPOINT THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 1350US2020255837A9Spherical nucleic acid tlr9 agonistsEXICURE INC·Filed 2017·Application pending·0 cites
- 1448US2021002640A1Liposomal spherical nucleic acid (sna) constructs for survival of motor neuron (sma) inhibitorsEXICURE INC·Filed 2019·Application pending·0 cites
- 1546US11696954B2Synthesis of spherical nucleic acids using lipophilic moietiesEXICURE OPERATING COMPANY·Filed 2018·Granted Jul 11, 2023·0 cites·13 claims
- 1640US2018042848A1Immuno-regulatory lipid containing spherical nucleic acidsEXICURE INC·Filed 2016·Application pending·0 cites
- 1739US2020248183A1Tlr9-targeted spherical nucleic acids having potent antitumor activityNALLAGATLA SUBBARAO·Filed 2017·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Subbarao Nallagatla files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →